Search

everythinglearnresearchcommunity

for

Search:↓

Taking Saw palmetto and Pygeum africana can change the levels of certain steroids in urine, which could cause confusion in doping tests.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Neurosteroids may help prevent seizures in epilepsy.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Hair hormone levels can indicate obesity-related changes and are useful for research and clinical practice.

Hair analysis for stress and reproductive hormones in wildlife needs more research for accuracy across species.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Endocrine disruptors may cause early hair loss.

Testosterone may slow down wound healing and increase inflammation.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Calculated testosterone values are reliable for assessing hyperandrogenemia in women, making direct measurement unnecessary.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.